Environmental Protection Commitment
- 【Environmental management system certification】
As required by Group policy, a member company of Sino Biopharmaceutical regularly carries out ISO14001 environmental management system certification, receives China Quality Certification Center (CQC) re-certification audit every 3 years, and receives CQC supervision and audit every year during the validity period, to ensure the continuous compliance and effectiveness of the environmental management system.
- 【Energy management system certification】
As required by Group policy, a member company of Sino Biopharmaceutical regularly carries out ISO14001 energy management system certification, receives China Quality Certification Center (CQC) re-certification audit every 3 years, and receives CQC supervision and audit every year during the validity period, to ensure the continuous compliance and effectiveness of the energy management system.
- 【Environmental compliance audit】
From February to June 2022, the Group carried out environmental compliance audit, covering member enterprises such as Chia Tai Tianqing, Nanjing Chia Tai Tianqing , Jiangsu Chia Tai Fenghai, Jiangsu Chia Tai Qingjiang, Shanghai Tongyong, etc. This work will continue to cover other member enterprises. The audit content includes the collection and disposal of three wastes (solid waste, liquid waste and gas waste) and the storage and management of hazardous chemicals. According to the audit results, relevant enterprises have completed the corresponding system management process rectification and equipment update; The renovation project of the organized emission of waste gas from manufacturers of raw material drugs are in progress or have been rectified.
- 【Hazardous Waste Emission Reduction】
The Group is committed to reducing hazardous waste generated in the process of production and operation. In 2021, member companies continued to improve the hazardous waste management mechanism and took various measures to reduce hazardous waste in the production and operation process, including reducing the amount of cleaning waste liquid by improving the utilization rate of equipment and reducing the production batch, introducing advanced sludge drying equipment to reduce the amount of sludge, optimize the process and refined management of raw and auxiliary materials to reduce hazardous waste at source.
For example, in the production process of rivaroxaban, Nanjing Chia Tai Tianqing uses low-toxic reagents to replace the reagents with high toxicity and strong volatility, and optimizes the reaction temperature parameters to reduce the volatilization of solvents, and uses inorganic alkali instead of organic alkali to reduce the production of organic waste liquid. At the same time, the amount of chemical reagents and catalysts were optimized to ensure the quality and reduce the use of reagents.